News
|
Careers
|
Contact Us
About Vanda
Development Pipeline
Discovery Research
Investor Relations
meet vanda
We are using pharmacogenetics to match promising molecules
to the right patients. So selecting the right medicine will be
easier, thanks to our more personal approach.
May 29, 2009
Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
May 14, 2009
Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
May 07, 2009
Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital
May 06, 2009
FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
Read More in the Newsroom
Fanapt™(iloperidone)
Tasimelteon